Company intelligence / Profile preview

TCD Pharma

Valladolid, Spaintcd.ie ↗

Ownership: Private
Development stage: Phase 1

Overview

TCD Pharma focuses on the discovery, development, and commercialization of innovative oncology drugs. It has been recognized as one of Spain's top biotech investment opportunities but no specific clinical results are publicly available[1][2][3][4].

Therapeutic areas: Oncology
Modalities: Small molecules
Industry: Biotech

Drug pipeline

1 asset

TCD-717

Phase 1

Indications: Cancer

Beyond the preview

Go deeper on TCD Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TCD Pharma.

Explore the full profile